Trade Analytics

Pharmaceutical Exports from India

Last Updated: November, 2016

Introduction

India is among the fastest-growing pharmaceutical markets in the world and has established itself as a global manufacturing and research hub. A large raw material base and the availability of a skilled workforce give the industry a definite competitive advantage. The Indian pharmaceutical industry is expected to grow at a compound annual growth rate (CAGR) of 22.4 per cent to touch US$ 55 billion by 2020, from US$ 20 billion in 2015.

India’s pharmaceutical space is dominated by generic drugs, which accounts for around 70 per cent of the market. India accounts for around 30 per cent (by volume) and about 10 per cent (value) in the US$ 70-80 billion US generics market.

EXPORTS AND ADVANTAGE INDIA

  • India is the largest supplier of generic medicines globally (20 per cent of global export volume)
  • Pharmaceutical export from India stood at US$ 12.54 billion in 2015, exhibiting a year-on-year growth of 7.55 per cent.
  • US Food and Drug Administration (USFDA) approvals to Indian companies totalled 201 in FY2015-16, up from 109 approvals received in FY2014-15.
  • India has one of the lowest manufacturing costs in the world. Manufacturing cost in India is approximately 35–40 per cent of that in the US as installation and workforce costs are low.
  • India is expected to rank amongst the top three pharmaceutical markets in terms of incremental growth by 2020.

PHARMACEUTICAL EXPORT PROMOTION COUNCIL

The Pharmaceutical Export Promotion Council (PHARMEXCIL) was established in 2004 by the Ministry of Commerce and Industry, Government of India, to promote pharma exports.

The Indian pharmaceutical industry is expected to touch US$ 55 billion by 2020.

Source:
Pharmaceutical Export Promotion Council (PHARMEXCIL)

The Indian pharmaceutical industry is expected to touch US$ 100 billion by 2025.

Source:
Pharmaceutical Export Promotion Council (PHARMEXCIL)

PHARMACEUTICAL E-BROCHURE

Other Export Promotion Councils:

Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.

Pharmexcil

101, Aditya Trade Centre
Ameerpet
Hyderabad - 500038
Andhra Pradesh
India

Tel.:+91-40-23735462/66
Fax: +91-40-23735464
Email: info@pharmexcil.com
Website: www.pharmexcil.com

The Indian pharmaceutical industry is expected to touch US$ 100 billion by 2025.

Source:
Pharmaceutical Export Promotion Council (PHARMEXCIL)

Exports

Pharmaceutical Exports from India